AllenP. J., and DowningJ. W. (1977): “A prospective study of hepatocellular function after repeated exposures to halothane or enflurane in women undergoing radium therapy for cervical cancer”.Brit. Anaesth., 49, 1035.
2.
BrownB. R., and SipesI. G. (1977): Commentary. “Biotransformation and hepatotoxicity of halothane”.Biochem. Pharmacol., 26, 2091–2094.
3.
CascorbiH. K., BlakeD. A., and HelrichM. (1970): “Differences in the biotransformation of halothane in man”, Anesthesiology, 32, 119–123.
4.
CohenE. N., TrudellJ. R., EdmundsH. N. (1975): “Urinary metabolites of halothane in man”.Anesthesiology, 43, 392.
5.
CousinsM. J., SharpJ. H., GourlayG. K., AdamsJ. F., HaynesW. D., and WhiteheadR. (1979): “Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity”.Anaesth. Intens. Care, 7, 383–398.
6.
DoughertyW. J., AltmanR. (1962): “Viral hepatitis in New Jersey 1960-1961”.Amer. J. Med., 32, 704.
7.
DonovanA. J. (1967): “The effect of surgery on reticulo-endothelial function”.Archives of Surgery, 94, 247.
8.
DouglasH. J., EgerE. I., BiavaC. G. (1977): “Hepatic necrosis associated with viral infection after enflurane anesthesia”.New. Eng. J. Med., 296, 553.
9.
DykesM. H. M. (1977): “Is halothane hepatitis chronic active hepatitis”?Anesthesiology, 46, 233.
10.
GradyG. (1977): “Hepatitis B from medical professionals: How rare? How preventable?”New. Eng. J. Med., 296, 996.
11.
JohnstoneM. (1978): “Halothane hepatitis”.Lancet, Sept. 2, p. 526.
12.
JohnstoneM. (1964): “Liver injury in the surgical patient. A critical review”.Brit. J. Anaesth., 36, 718.
13.
McEwanJ. (1976): “Liver function tests following anaesthetics”.Brit. J. Anaesth., 48, 1065.
14.
MoultP. J., and SherlockS. (1975): “Halothane related hepatitis. A clinical study of twenty-six cases”.Quat. Ql. Med.XLIV, 173, 99.
15.
National Halothane Study (1969): “A study of the possible association between halothane anesthesia and post-operative hepatic necrosis. (Ed.) BunkerJ. P.WashingtonU.S. Govt. Printing Office.
16.
MukaiS., MorioM. (1977): “Volatile metabolites of halothane in the rabbit”.Anesthesiology, 47, 248–251.
17.
RimlandD., ParkinW., MillerG. D. (1977): “Hepatitis B outbreak traced to an oral surgeon”.New Eng. J. Med., 296, 955.
18.
SharpJ. H., TrudellJ. R., and CohenE. N. (1978): “Volatile metabolites and decomposition products of halothane in man”,Anesthesiology.
19.
SherlockS. (1978): “Point of view. Halothane hepatitis”.Lancet, Aug. 12, p. 364.
20.
StevensW. C., EgerE. I., WhiteA. (1975): “Comparative toxicities of halothane, isoflurane and diethyl ether at subanaesthetic concentrations in laboratory animals”.Anesthesiology, 42, 408.
21.
StruninL. (1977): “The liver and anaesthesia”.W. B. Saunders, London, p. 145–181.
22.
StruninL. (1978): “Halothane hepatitis”.Lancet, Aug. 26, p. 468.
23.
TrowellJ., PetoR., and Crampton-SmithA. (1975): “Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium”.Lancet, i, 821.
24.
Van DykeR. A., and WoodC. L. (1973): “Binding of radioactivity from C14 labelled halothane in isolated perfused rat livers”.Anesthesiology, 36, 328.
25.
Van DykeR. A., and GandolfiA. J. (1976): “Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents”.Drug. Metab. Disp.4, 40–44.
26.
VergagniD., TsantoulasD., EddlestonA. L. (1978): “Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia”.Lancet, Oct. 14, 802–803.
27.
WaltonB. (1978): “Anaesthesia, surgery and immunology”.Anaesthesia, 33, 322–348.
28.
WaltonB., SimpsonB. R., StruninL. (1976): “Unexplained hepatitis following halothane”.Brit. Med. J.1, 1171.
29.
WillsE. J., and WaltonB. (1978): “A morphologic study of unexplained hepatitis following halothane anesthesia”.Amer. J. Path.1, 11–26.
30.
WrightR., ChisholmM., LloydB. (1975): “Controlled prospective study of the effect on liver function of multiple exposure to halothane”.Lancet, i, 821.